Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Submitted by
admin
on July 17, 2012 - 11:27am
Source:
Reuters
News Tags:
Vivus
Orexigen
Contrave
obesity
Qnexa
Headline:
Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Do Not Allow Advertisers to Use My Personal information
